Tectonic Therapeutic, Inc.

Stock Chart, Company Information, and Scan Results

$34(as of Mar 9, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Tectonic Therapeutic, Inc. Company Information, Fundamentals, and Technical Indicators

Stock Price$34
Ticker SymbolTECX
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees60
CountyUSA
Market Cap$673.5M

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

Tectonic Therapeutic, Inc. In Our Stock Scanner

As of Mar 09, 2026
As of ---
As of ---
example chart graphic
Scan Name: 52-Week HighScan Type: Stock Fundamentals
As of ---
As of ---
example chart graphic
Scan Name: Cash SurplusScan Type: Stock Fundamentals
As of ---
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.